{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T02:04:14Z","timestamp":1747188254099,"version":"3.40.5"},"reference-count":40,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>The current study analysed the viral safety among Iranian blood donors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>Plasma products demand is increasing in the world. With contract plasma fractionation, the plasma wastage decreases and the access of patients to plasma\u2010derived medicines (PDM) improves.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study and Design Method<\/jats:title><jats:p>Screening results including hepatitis B surface antigen (HBsAg), anti\u2010hepatitis C virus (HCV), and human immunodeficiency virus (HIV) Ag\/Ab of 19\u2009054\u2009036 donations from 2006 to 2015 were analysed. The plasma for fractionation was tested for HBV DNA, HCV RNA, HIV RNA, HAV RNA, and Parvovirus B19 DNA by fractionators. New samples were collected from the positive donors and retested. The prevalence of serological and nucleic acid testing (NAT) markers per 10<jats:sup>5<\/jats:sup> donations, 95% confidential interval (CI), and <jats:italic>p<\/jats:italic>\u2010values were calculated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The prevalence of markers was as follows: 250\/10<jats:sup>5<\/jats:sup> donations for HBsAg from 516 in 2006 to 116\/10<jats:sup>5<\/jats:sup> donations in 2015; 74\/10<jats:sup>5<\/jats:sup> donations for HCV, decreasing from 127 to 41\/10<jats:sup>5<\/jats:sup> and 3.6\/10<jats:sup>5<\/jats:sup> for HIV during current study. During 10\u2009years, 5\u2009713\u2009641\u2009units of recovered plasma were shipped for contract fractionation to produce PDM; 0.26\/10<jats:sup>5<\/jats:sup> donations for HBV DNA and 0.14\/10<jats:sup>5<\/jats:sup> for HCV RNA were reported positive. The results of five retested samples for HBV and one sample for HCV were negative.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The prevalence of HBV, HCV, and HIV in blood donations was extremely low. Thanks to the availability, high quality and safety of recovered plasma as a result of the improvements in the quality system at IBTO, this plasma could be used for the production of PDMPs.<\/jats:p><\/jats:sec>","DOI":"10.1111\/tme.12833","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T08:43:08Z","timestamp":1637916188000},"page":"64-70","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Viral safety of recovered plasma for contract fractionation; an Iranian experience, 2006\u20132015"],"prefix":"10.1111","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0441-9004","authenticated-orcid":false,"given":"Sedigheh","family":"Amini\u2010Kafiabad","sequence":"first","affiliation":[{"name":"Department of Pathology, Blood Transfusion Research Center High Institute for Research and Education in Transfusion Medicine  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Akbar","family":"Pourfatollah","sequence":"additional","affiliation":[{"name":"Department of Immunology, Faculty of Medical Science Tarbiat Modares University  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2824.2011.01517.x"},{"key":"e_1_2_9_3_1","unstructured":"World Health OrganizationImproving access to safe blood products through local production and technology transfer in blood establishment. 8\u201328 2015"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01936.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.2009.00935.x"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02245.x"},{"issue":"8","key":"e_1_2_9_7_1","first-page":"89","article-title":"Overview of blood transfusion system of Iran: 2002\u20102011","volume":"41","author":"Cheraghali A","year":"2012","journal-title":"Iran J Public Health"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12214"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00911.x"},{"issue":"1","key":"e_1_2_9_10_1","first-page":"39","article-title":"Blood safety overview in Iran","volume":"18","author":"Amini\u2010Kafiabad S","year":"2015","journal-title":"Arch Iran Med"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.2002.00383.x"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2012.01635.x"},{"issue":"5","key":"e_1_2_9_13_1","first-page":"387","article-title":"Detection of hepatitis B virus DNA (PCR) in HBsAg negative, anti\u2010HBc positive blood donors in Tehran province","volume":"3","author":"Amini Kafi\u2010abad S","year":"2007","journal-title":"Sci J Iran Blood Transfus Organ"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-016-0492-8"},{"issue":"3","key":"e_1_2_9_15_1","first-page":"13","article-title":"Detection of hepatitis B virus DNA (PCR) in HBsAg negative, anti\u2010HBc positive blood donors in Tehran province","volume":"2","author":"Amini Kafi\u2010abad S","year":"2005","journal-title":"Sci J Iran Blood Transfus Organ"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.2004.00601.x"},{"issue":"3","key":"e_1_2_9_17_1","first-page":"179","article-title":"Prevalence of hepatitis C virus antibodies among blood donors in northern Jordan","volume":"42","author":"Rashdan A","year":"2008","journal-title":"Jordan Med J"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1413-8670(10)70009-X"},{"issue":"2","key":"e_1_2_9_19_1","first-page":"41","article-title":"Prevalence of hepatitis B and C in donated blood from the Jazan region of Saudi Arabia","volume":"20","author":"Mohammed Abdullah S","year":"2013","journal-title":"Malays J Med Sci"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2013.11.005"},{"key":"e_1_2_9_21_1","first-page":"473","article-title":"Blood donor screening for blood born viruses in Poland","volume":"69","author":"Grabarczyk P","year":"2015","journal-title":"Przegl Epidemiol"},{"issue":"10","key":"e_1_2_9_22_1","first-page":"1046","article-title":"Prevalence of hepatitis B and C among blood donors attending the National Blood Transfusion Center in Baghdad, Iraq from 2006\u20102009","volume":"32","author":"Ataallah TM","year":"2011","journal-title":"Saudi Med J"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.8160"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00635.x"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000094271"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-20"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.6666"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007644"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12521"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.4103\/GJTM.GJTM_8_17"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2011.01506.x"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01718.x"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01108.x"},{"issue":"15","key":"e_1_2_9_34_1","first-page":"1","article-title":"Residual risk of hepatitis\u2010B\u2010infected blood donations: estimation methods and perspectives","volume":"13","author":"Kupek E","year":"2013","journal-title":"ISRN Infect Dis"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.18869\/acadpub.jbrms.4.2.4"},{"issue":"6","key":"e_1_2_9_36_1","first-page":"137","article-title":"Evaluation of nucleic acid testing for blood donors: four\u2010year study of the Egyptian population","volume":"6","author":"Mohamed SA","year":"2016","journal-title":"Clin Med Diagn"},{"key":"e_1_2_9_37_1","first-page":"174","article-title":"Diagnostic algorithm for HBV safe transfusion","volume":"7","author":"Allain JP","year":"2009","journal-title":"Blood Transfus"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1159\/000457965"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0042-9007.2004.00406.x"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01781-09"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.40492"}],"container-title":["Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tme.12833","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/tme.12833","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tme.12833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T08:55:08Z","timestamp":1693212908000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tme.12833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1111\/tme.12833"],"URL":"https:\/\/doi.org\/10.1111\/tme.12833","archive":["Portico"],"relation":{},"ISSN":["0958-7578","1365-3148"],"issn-type":[{"type":"print","value":"0958-7578"},{"type":"electronic","value":"1365-3148"}],"subject":[],"published":{"date-parts":[[2021,11,24]]},"assertion":[{"value":"2021-05-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}